Potential Use of CTCs as Biomarkers in Renal Cancer Patients.

Bialek J, Wencker A, Kawan F, Yankulov S, Fornara P, Theil G

Open source

DOI
10.3390/life12010089
Published
2022 Jan 9
Container
Life (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/life12010089,
  title = {Potential Use of CTCs as Biomarkers in Renal Cancer Patients.},
  author = {Bialek J and Wencker A and Kawan F and Yankulov S and Fornara P and Theil G},
  year = {2022},
  journal = {Life (Basel, Switzerland)},
  doi = {10.3390/life12010089},
  url = {https://doi.org/10.3390/life12010089}
}

RIS

TY  - JOUR
TI  - Potential Use of CTCs as Biomarkers in Renal Cancer Patients.
AU  - Bialek J
AU  - Wencker A
AU  - Kawan F
AU  - Yankulov S
AU  - Fornara P
AU  - Theil G
PY  - 2022
JO  - Life (Basel, Switzerland)
DO  - 10.3390/life12010089
UR  - https://doi.org/10.3390/life12010089
ER  - 

APA

J, B., A, W., F, K., S, Y., P, F., & G, T. (2022). Potential Use of CTCs as Biomarkers in Renal Cancer Patients.. Life (Basel, Switzerland). https://doi.org/10.3390/life12010089

Source records